Asia Pacific

Liquid Learning is delighted to present the Women in Pharma and Medical Leadership Summit. A unique platform in New Zealand for professional development and networking with current and emerging female leaders in the medical and pharmaceutical sector.  Focused on bringing industry experts from across the pharma and medical sector to…
TOT BIOPHARM Co Ltd. and LEE'S PHARMACEUTICAL HOLDINGS LIMITED jointly announced that LEE'S PHARM, through its wholly-owned subsidiary Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited has acquired the exclusive license of TAB014, the monoclonal antibody drug developed and manufactured by TOT BIOPHARM, within China. TAB014 is a new antibody product that can…
3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform                                         Established as Asia’s leading exhibition for the medical technology, medical manufacturing processes…
Natco Pharma Limited announced that its marketing partner, Mylan Inc has received a tentative approval for its Abbreviated New Drug Application (ANDA) for Sorafenib Tablets, 200mg, with the U.S. FDA.   This product is the generic version of NEXAVAR®, which is indicated for the treatment of certain types of cancers…
Eisai Co Ltd announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S.  FDA  for an additional  indication for Eisai's in-house developed novel anticancer agent Lenvima® (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.…
Page 1 of 6

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: